We provide external medical peer reviews and independent health care review services for government agencies and large health care providers, and help them control escalating health care costs while providing appropriate medical care. And we've been doing it for over 36 years.
Monday, June 22, 2015
Alcoholic Hepatitis - Pipeline Review, H1 2015 - 6 Companies & 7 Drug Profiles
. Buy Arginine online About Viagra Caps (Sildenafil Citrate) with free prescription DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/6b94zk/alcoholic)
has announced the addition of the "Alcoholic
Hepatitis - Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Alcoholic Hepatitis, complete with comparative analysis
at various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. http://medicalquestionanswers.wordpress.com Buy Actonel with free prescription About Atarax (Hydroxyzine) with free Rx It also
reviews key players involved in the therapeutic development for
Alcoholic Hepatitis and special features on late-stage and discontinued
projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. Buy Voltaren (Diclofenac) About Viagra Super Dulox-Force (Sildenafil Citrate + Duloxetine) It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
Alfact Innovation
Conatus Pharmaceuticals Inc.
Generon (Shanghai) Corporation Ltd.
Immuron Limited
Intercept Pharmaceuticals, Inc.
Oncozyme Pharma Inc.
Drug Profiles
ALF-5755
emricasan
F-652
IMM-124E
obeticholic acid
Oligonucleotide to Inhibit miRNA-155 for Alcoholic Liver Disease
pentamidine isethionate
For more information visit .researchandmarkets.com/research/6b94zk/alcoholic
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment